Skip to main content
SpringerLink
Log in

Viruses, Immunity, and Cancer

  • Chapter
Immunological Aspects of Cancer

Part of the book series: Developments in Oncology ((DION,volume 21))

  • 68 Accesses

Abstract

Reading the scientific and medical literature is difficult without feeling swamped by suggested causes of human cancer: genetic factors have been implicated; epidemiological studies based on geographic variations in cancer incidence have suggested a variety of environmental factors [1]; multiple elements in our food and diet have been indicted at various times; and many fashions of western and eastern society have been held to contain factors that increase the incidence of malignant diseases [2]. With this in mind, it is not surprising that virus infection has been associated with the aetiology of cancer; however, this theory deserves attention, since it is supported by a large body of circumstantial evidence, and under strictly controlled conditions, viruses can be shown to induce many forms of cancer in a variety of animal species. These observations have led many authorities to suggest that viruses are aetiological agents of malignant disease in man, but the inability to carry out the experiments that proved the association of viruses and cancer in animals has meant that direct proof of association cannot be made for human cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cairns J. The cancer problem. Sci Amer 233: 64–72, 1975.

    Article  PubMed  CAS  Google Scholar 

  2. Weisburgher JH, Williams GM. Metabolism of chemical carcinogens. In Becker FF (ed.), Cancer. Etiology; chemical and physical carcinogenesis. New York: Plenum Press, 1975.

    Google Scholar 

  3. Ellerman V, Bang O. Experimentelle leukaemie bei huhnern. Centr Bakteriol Abt 1: 559–601, 1908.

    Google Scholar 

  4. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumour cells. J Exp Med 13: 397–411, 1911.

    Article  PubMed  CAS  Google Scholar 

  5. Moses A. O virus do mixoma dos collhos. Mem Inst Oswald-Cruz. 3: 46–53, 1911.

    Article  Google Scholar 

  6. Shope RE. Filterable virus causing tumour-like condition in rabbits and its relationship to virus myxomatosum. J Exp Med 56: 803–822, 1932.

    Article  PubMed  CAS  Google Scholar 

  7. Shope RE. Infectious papillomatosis of rabbits. J Exp Med 58: 607–625, 1933.

    Article  PubMed  CAS  Google Scholar 

  8. Furth J. Lymphomatosis, myelomatosis and endothelioma of chickens caused by a filterable agent. J Exp Med 58: 253–275, 1933.

    Article  PubMed  CAS  Google Scholar 

  9. Bittner JJ. Some possible effects of nursing on mammary gland tumour incidence in mice. Science 84: 162, 1936.

    Article  PubMed  CAS  Google Scholar 

  10. Lucke B, Carcinoma of the leopard frog: Its probable causation by a virus. J Exp Med 68: 457–468, 1938.

    Article  PubMed  CAS  Google Scholar 

  11. Sweet BH, Hilleman MR. The vacuolating virus SV40. Proc Soc Exp Biol Med 105: 420–427, 1960.

    PubMed  CAS  Google Scholar 

  12. Rabson AS, O’Connor GT, Kirschstein RL, Branigan WJ. Papillary ependymomas produced in Rattus (Mastomys) Natalensis inoculated with vacuolating virus (SV40). J Natl Cancer Inst 29: 765–787, 1962.

    PubMed  CAS  Google Scholar 

  13. Trenton JJ, Yabe Y, Taylor G. The quest for human cancer viruses. Science 137: 835–841, 1962.

    Article  Google Scholar 

  14. Huebner RJ. Adenovirus-directed tumour and T-antigens. In Pollard M (ed.), Perspectives in virology. 5: 147–166, 1967.

    Google Scholar 

  15. Jordan WS, Badger GF, Dingle JH. A study of type-specific adenovirus antibodies in the first five years of life—Implications for the use of adenovirus vaccine. N Eng J Med 258: 1041–1044, 1958.

    Article  Google Scholar 

  16. Tooze J. Structure and composition of polyoma, SV40 and the Papillomaviruses. In Watson J (ed.), Origins of human cancer. New York: Cold Spring Harbor, 1977.

    Google Scholar 

  17. Zur Hausen H. Human Papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78: 1–30, 1977.

    PubMed  Google Scholar 

  18. Stewart SE, Eddy BE, Borgese N. Neoplasms in mice inoculated with a tumour agent carried in tissue culture. J Nat Cancer Inst 20: 1223–1236, 1958.

    PubMed  CAS  Google Scholar 

  19. Carr I, McGinty FM, Potter CW. Neoplastic metastasis of transplantable animal neoplasms. Experimenta 3D: 185–186, 1974.

    Article  Google Scholar 

  20. Huebner RJ. Tumours induced by adenoviruses. In Pollard M (ed.), Perspectives in virology. New York: Academic Press, 1967.

    Google Scholar 

  21. Sarma PS, Heubner RJ, Lane WT. Induction of tumours in hamsters with an avian adenovirus (CELO). Science 149: 1108, 1965.

    Article  PubMed  CAS  Google Scholar 

  22. Hull RN, Johnson IS, Cuthbertson CG, Reimer CB, Wright HF. Oncogenicity of the simian adenoviruses. Science 150: 1044–1046, 1965.

    Article  PubMed  CAS  Google Scholar 

  23. Gilden RJ, Kern J, Beddow TG, Heubner RJ. Bovine adenovirus type 3: Detection of specific tumour and T-antigens. Virology 31: 727–729, 1967.

    Article  PubMed  CAS  Google Scholar 

  24. Brandt CD, Kim HW, Varsosky AJ, Jeffries BC, Arrobio JO, Rindge B, Parrott RH, Chanock RM. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I Adenoviruses. Amer J Epidemiol 90: 484–500, 1969.

    CAS  Google Scholar 

  25. Potter CW, Sheddon WIH. The distribution of adenovirus antibodies in normal children. J Hyg (Camb.) 61: 155–160, 1963.

    Article  CAS  Google Scholar 

  26. Potter CW, Schild GC. Antibodies in human sera to adenoviruses (types 7, 12, and 18). Arch Ges Virus- forsch 18: 80–87, 1966.

    Google Scholar 

  27. Green M, Mackey JK. Are oncogenic human adenoviruses associated with human cancer? Cold Spring Har-bor Conf. Cell Proliferation 4: 1027–1031, 1977.

    CAS  Google Scholar 

  28. Rafferty KA. The cultivation of inclusion-associated viruses from Lucke tumours frogs. Ann NY Acad Sci 126: 3–21, 1965.

    Article  PubMed  Google Scholar 

  29. Naegele RF, Granoff A, Darlington RW. The presence of the Lucke’ Herpesvirus genome in induced tadpole tumours and its oncogenicity. Proc Natl Acad Sci (USA) 71: 830–834, 1974.

    Article  CAS  Google Scholar 

  30. Purchase HG: Marek’s disease virus and the Herpesvirus of turkeys. Prog Med Virol 18: 178–197, 1974.

    PubMed  CAS  Google Scholar 

  31. Payne LN, Biggs PM. Studies on Marek’s disease. II. Pathogenesis. J Natl Cancer Inst 39: 281–291, 1967.

    Google Scholar 

  32. Hunt RD, Melendez LV, Garcia G, Trum BF. Pathologic features of Herpesvirus ateles lymphoma in cotton- topped marmosets (Saguinas oedipus). J Natl Cancer Inst 49: 1631–1638, 1972.

    PubMed  CAS  Google Scholar 

  33. Niven JSF, Armstrong JA, Andrewes CH, Pereira HG, Valentine RC. Subcutaneous growths in monkeys produced by a poxvirus. J Path Bact 81: 1–14, 1961.

    Article  PubMed  CAS  Google Scholar 

  34. Blair FB. The mammary tumour virus (MTV). In Current topics in microbiology. New York: Springer Verlag 45: 1–69, 1968.

    Google Scholar 

  35. Hageman PC, Calafat J, Daams JH. The mouse mammary tumour viruses. In Emmelot P, Bentvelsen P (eds.), RNA viruses and the host genome in oncogenesis. Amsterdam: North Holland, 1972.

    Google Scholar 

  36. Panem S, Reynolds JT. Retrovirus expression in normal and pathogenic processes of man. Fed Proc 38: 2674–2678, 1979.

    PubMed  CAS  Google Scholar 

  37. Essex M, Cotter SM, Hardy WD, Hess P, Jarrett W, Jarrett O, Mackey L, Laid H, Perryman L, Olsen RG, Young DS. Antibody titres in cats with naturally occurring leukaemia, lymphoma and other diseases. J Nat Cancer Inst 55: 463–467, 1975.

    PubMed  CAS  Google Scholar 

  38. Theilen GH, Wolfe LG, Rabin H, Deinhardt F, Dungworth DL, Fowler ME, Gould D, Cooper R. Biological studies of four species of nonhuman primates with simian sarcoma virus. Bibl Haematol 39: 251–257, 1973.

    PubMed  CAS  Google Scholar 

  39. McAllister RM, Nicolson MO, Reed G, Kern J, Gilden RV, Huebner RJ. Transformation of rodent cells by adenovirus 19 and other group D adenoviruses. J Natl Cancer Inst 43: 917–922, 1969.

    PubMed  CAS  Google Scholar 

  40. Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO. Induction of mammary fibroadenomas in rats by adenovirus type 9. Int J Cancer 13: 286–290, 1974.

    Article  PubMed  CAS  Google Scholar 

  41. Monoz N. Effect of Herpesvirus type 2 and hormonal imbalance in uterine cervix of the mouse. Cancer Res 33: 1504–1508, 1973.

    Google Scholar 

  42. Wentz WB, Facog JW, Reagan JW, Heggie AD. Cervical carcinigenesis with herpes simplex virus type 2. Amer J Obs Gyn 46: 117–121, 1975.

    CAS  Google Scholar 

  43. Potter CW. Some aspects of the role of viruses in cancer. Postgrad Med J 55: 150–158, 1979.

    Article  PubMed  CAS  Google Scholar 

  44. Boyd AL. Characterization of single-cell clonal lines derived from HSV-2 transformed mouse cells. In- tervirol 6: 156–167, 1975.

    Google Scholar 

  45. Potter CW, Shortland JR, Mousway KM, Rees, RC. Comparative studies of transformed hamster cells by Herpesvirus hominis types 1 and 2. Brit J Exp Path 63: 285–298, 1982.

    PubMed  CAS  Google Scholar 

  46. Todaro, GJ, Green H, Swift MR. Susceptibility of human diploid fibroblast strains to transformation by SV40. Science 153: 1252–1254, 1966.

    Article  PubMed  CAS  Google Scholar 

  47. Butel JS, Brugge JS, Noonan CA. Transformation of primate and rodent cells by temperature-sensitive mutants of SV40. In Tumour Viruses (Cold Spring Harbour Symp.) 34: 25–36, 1974.

    Google Scholar 

  48. Duff R, Rapp F. Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature 233: 48–50, 1971.

    Article  CAS  Google Scholar 

  49. Rapp F, Westmoreland D, Cell transformation by DNA-containing viruses. Biochimica Biophysica Acta 458: 167–211, 1976.

    CAS  Google Scholar 

  50. Aaronson SA. Susceptibility of human cell strains to transformation by simian virus SV40 and simian virus deoxyribonucleic acid. J Virol 6: 470–475, 1970.

    PubMed  CAS  Google Scholar 

  51. Casto BC, Adenovirus transformation of hamster embryo cells. J Virol 2: 376–383, 1968.

    PubMed  CAS  Google Scholar 

  52. Sambrook J. Transformation by Polyomavirus and simian virus 40. Adv Cancer Res 16: 141–180, 1972.

    Article  PubMed  CAS  Google Scholar 

  53. Rabson AS, Kirchstein RL. Induction of malignancy in vivo in newborn hamster kidney tissue infected with simian vacuolating virus (SV40). Proc Soc Exp Biol Med 111: 323–328, 1962.

    PubMed  CAS  Google Scholar 

  54. Jensen F, Koprowski H, Ponton JA. Rapid transformation of human fibroblast cultures by simian virus 40. Proc Nat Acad Sci 50: 343–348, 1963.

    Article  PubMed  CAS  Google Scholar 

  55. Todaro GJ, Aaronson SA. Human cell strains susceptible to focus formation by human adenovirus type 12. Proc Nat Acad Sci 61: 1272–1278, 1968.

    Article  PubMed  CAS  Google Scholar 

  56. Green M. DNA and RNA tumour viruses—molecular events of virus replication and cell transformation and role in human cancer. Adv Pathbiol 2: 10–23, 1976.

    CAS  Google Scholar 

  57. Galloway DA, McDougall JK. Transformation of rodent cells by a cloned DNA fragment of herpes simplex virus type 2. J Virol 38: 749–760, 1981.

    PubMed  CAS  Google Scholar 

  58. Wyke JA. Oncogenic viruses. J Pathol 135: 39–85, 1981.

    Article  PubMed  CAS  Google Scholar 

  59. Sambrook J, Westphal H, Srinvasan PR, Dulbecco R. The integrated state of viral DNA in SV40-trans- formed cells. Proc Nat Acad Sci 60: 1288–1295, 1968.

    Article  PubMed  CAS  Google Scholar 

  60. Butel JS, Brugge TC, Noonan CA. Transformation of primate and rodent cells by temperature sensitive mutants of SV40: Cold Spring Harbour Symp. Quant Biol 39: 25–31, 1974.

    Google Scholar 

  61. Carroll RB, Smith AG. Monomer molecular weight of T antigen from simian virus 40-infected and trans¬formed cells. Proc Soc Exp Biol, Med 73: 2254–2258, 1976.

    CAS  Google Scholar 

  62. Rubin H, Figge J, Bladon MT, Chen LB, Ellman M, Bikel I, Farrel M, Livingston DM: Role of small t an¬tigen in the acute transforming activity of SV40. Cell 30: 469–480, 1982.

    Article  PubMed  CAS  Google Scholar 

  63. Levine AJ. Transformation-associated tumour antigens. Adv. Cancer Res 37: 75–109, 1982.

    Article  PubMed  CAS  Google Scholar 

  64. Hanafiisa H. Cell transformation by RNA tumour viruses. In Fraenkel-Conrat H, Wagner R (eds.), Com-prehensive virology. New York: Plenum Press, vol 10, 1977.

    Google Scholar 

  65. Vogt PK. The genetics of RNA tumour viruses. In Fraenkel-Conrat H, Wagner R (eds.), Comprehensive virology. New York: Plenum Press, vol 10, 1977.

    Google Scholar 

  66. Hunter T, Sefton BM. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci 77: 1311–1315, 1980.

    Article  PubMed  CAS  Google Scholar 

  67. Hayman MJ. Transforming proteins of avian retroviruses. J Gen Virol 52: 1–14, 1981.

    Article  PubMed  CAS  Google Scholar 

  68. Brugg JS, Erikson RL. Identification of a transformation specific antigen induced by avian sarcoma virus. Nature 269: 346–348, 1977.

    Article  Google Scholar 

  69. Duesbery PH. Transforming genes of retroviruses. Cold Spring Harbour Symp. Quant Biol 44: 13–21, 1980.

    Google Scholar 

  70. Shih TY, Weeks MO, Young HA, Scolnick EM. Identification of a sarcoma virus coded phosphoprotein in the non-producer cells transformed by Kirsten or Harvey murine sarcoma viruses. Virology 96: 64–79, 1979.

    Article  PubMed  CAS  Google Scholar 

  71. Graf T, Beug H. Avian leukaemia viruses. Interaction with their target cells, in vivo and in vitro. Biochim Biophys Acta 516: 269–299, 1978.

    Google Scholar 

  72. De Larco JE, Tadaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Nat Acad Sci 75: 4001–4005, 1978.

    Article  PubMed  Google Scholar 

  73. Langan T. Malignant transformation and protein phosphorylation. Nature 286: 329–330, 1980.

    Article  PubMed  CAS  Google Scholar 

  74. Weil R. Viral “tumour antigen”: A novel type of mammalian regulator protein. Biochim Biophys Acta 516: 310–388, 1978.

    Google Scholar 

  75. Hayward WS, Weel BG, Astrin SM. Avian lymphoid leukosis is correlated with the appearance of discrete new RNAs containing viraland cellular genetic information: In Neth R, Gallo R (eds.), Modern trends in human leukaemia. Munich: Bergerman Verlag, 1981.

    Google Scholar 

  76. Stephenson JR. Type C virus structural and transformation-specific proteins. In Stephenson JR (ed.), Molecular biology of RNA tumour viruses. New York: Academic Press, 1980.

    Google Scholar 

  77. Old LJ, Stockert E. Immunogenetics of cell surface antigens of mouse leukaemia. Anns Rev Genet 11: 127–160, 1977.

    Article  CAS  Google Scholar 

  78. Coggin JH, Ambrose KR. Embryonic and foetal determinants on virally and chemically induced tumours. Methods Cancer Res 18: 371–389, 1979.

    Google Scholar 

  79. Black PH, Rowe WP, Turner HC, Huebner RJ. A specific complement-fixing antigen present in SV40 tumour and transformed cells. Proc Nat Acad Sci 50: 1148–1156, 1963.

    Article  PubMed  CAS  Google Scholar 

  80. Potter CW, McLaughlin BC, Oxford JS. Simian virus 40-induced T and tumour antigen. J Virol 4: 574– 579, 1969.

    Google Scholar 

  81. Ahmed-Zadeh C, Allet B, Greenblatt J, Weil R. Two forms of the simian virus-40-specific T-antigen in abortive and lytic infection. Proc Nat Acad Sci 73: 1097–1101, 1976.

    Article  Google Scholar 

  82. Pope JH, Rowe WP. Detection of specific antigen in SV40-transformed cells by immunofluorescence. J Exp Med 120: 121–128, 1964.

    Article  PubMed  CAS  Google Scholar 

  83. Schild GC, Oxford JS, Potter CW. Changes accompanying long-term tissue culture of an adenovirus type 12 tumour cell line. Brit J Cancer 22: 798–807, 1968.

    Article  PubMed  CAS  Google Scholar 

  84. Anderson JL, Martin RG, Chang C, Mora PT, Livingstone D. Nuclear preparations of SV40-transformed cells contain tumour specific transplantation antigen activity. Virology 76: 420–425, 1977.

    Article  PubMed  CAS  Google Scholar 

  85. Girardi AJ. Prevention of SV40 virus oncogenesis in hamsters. I. Tumour resistance induced by human cells tranformed by SV40. Proc Nat Acad Sci 54: 445–451, 1965.

    Article  PubMed  CAS  Google Scholar 

  86. Potter CW, Hoskins JM, Oxford JS. Immunological relationship of some oncogenic DNA viruses. I. Transplantation immunity studies. Arch Ges Virusforsch 27: 73–86, 1969.

    Article  PubMed  CAS  Google Scholar 

  87. Zarling JM, Tevethia SS. Transplantation immunity to simian virus-40 transformed cells in tumour bearing mice. I. Development of cellular immunity to simian virus 40 tumour specific transplantation antigens dur¬ing tumourigenesis by transformed cells. J Natl Cancer Inst 50: 137–147, 1980.

    Google Scholar 

  88. Tevethia SS, Greenfield RS, Flyer DC, Tevethia MJ. SV40 transplantation antigen: Relationship to SV40- specific proteins. Cold Spring Harbour Symp. Quant Biol 44 (Pt. 1): 235–242, 1980.

    CAS  Google Scholar 

  89. Smith RW, Morganroth J, Mora PT. SV40 virus-induced tumour specific transplantation antigen in cul¬tured mouse cells. Nature 227: 141–145, 1971.

    Article  Google Scholar 

  90. Rogers MJ, Low LW. Immunogenic properties of a soluble tumour rejection antigen (TSTA) from a simian virus 40-induced sarcoma. Int J Cancer 23: 89–96, 1979.

    Article  PubMed  CAS  Google Scholar 

  91. Lewis AM Jr, Rowe WP. Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VIII. Association of simian virus 40 transplantation antigen with a specific region of the early viral genome. J Virol 12, 836–840, 1973.

    PubMed  Google Scholar 

  92. Girardi AJ, Defendi V. Induction of SV40 transplantation antigen (TrAg) during the lytic cycle J Virol 42, 688–698, 1970.

    CAS  Google Scholar 

  93. Tegtmeyer P, Schwatz M., Collins JK, Rundell K. Regulation of tumour antigen synthesis by simian virus 40 gene. J Virol 16: 168–178, 1975.

    PubMed  CAS  Google Scholar 

  94. Crawford LV, Pim DC, Lane DP. An immunochemical investigation of SV40 T antigens. II. Quantitation of antigen and antibody activities. Virology 100: 314–325, 1980.

    Article  PubMed  CAS  Google Scholar 

  95. Greenfield RS, Flyer DC, Tevethia SS. Demonstration of unique and common antigenic sites located on the SV40 large T and small t antigens. Virology 104, 312–322, 1980.

    Article  PubMed  CAS  Google Scholar 

  96. Chang C, Martin RG, Livingston DM, Luborsky SW, Hu C, Mora PT. Relationship between T-antigen and tumour specific transplantation antigen in simian virus 40 transformed cells. J Virol 29: 69–75, 1979.

    PubMed  CAS  Google Scholar 

  97. Morrow JF, Berg P, Kelly TJ Jr., Lewis AM Jr. Mapping of simian virus 40 early functions on the viral chromosome. J Virol 12, 653–658, 1973.

    PubMed  CAS  Google Scholar 

  98. Jay G, Jay FT, Chang C, Friedman RM, Levrin AS. Tumour specific transplantation antigen: Use of the Ad2+ NDj hybrid virus to identify the proteins responsible for simian virus 40 tumour rejection and its genetic origin. Proc Natl Acad Sci 75, 3055–3059, 1978.

    Article  PubMed  CAS  Google Scholar 

  99. Jay G, Jay FT, Chang C, Levine AS, Friedman RM. Induction of simian virus 40-specific tumour rejection by the Ad2+ ND2 hybrid virus. J Gen Virol 44: 287–296, 1979.

    Article  PubMed  CAS  Google Scholar 

  100. Tevethia SS, Flyer DC, Trian R. Biology of simian virus 40 (SV40) transplantation antigen (TrAG). Virology 107: 13–23, 1980.

    Article  PubMed  CAS  Google Scholar 

  101. Law LW, Rogers MJ, Apella E. Tumour antigens in neoplasms induced by chemical carcinogens and by DNA and RNA-containing viruses: Properties of the solubilised antigens. Adv Cancer Res 32: 201–215, 1980.

    Google Scholar 

  102. Duff R, Doller E, Rapp F. Immunologic manipulation of metastases due to Herpesvirus transformed cells. Science 180: 79–81, 1973.

    Article  PubMed  CAS  Google Scholar 

  103. Mousawy KM, Rees RC, Potter CW. Immunogenic properties of hamster tumours of Herpesvirus hominis aetiology. Cancer Immunol Immunother 8: 119–126, 1980.

    Article  Google Scholar 

  104. Baver H. Virion and tumour antigens of C-type RNA tumour viruses. Adv Cancer Res 20: 275–341, 1975.

    Google Scholar 

  105. Old LJ, Boyse EA, Stockert E. The G(Gross) leukaemia antigen. Cancer Res 25: 813–819, 1965.

    PubMed  CAS  Google Scholar 

  106. Geering G, Old LJ, Boyse EA. Antigens of leukaemia induced by naturally occurring murine leukaemia virus: Their relation to the antigen of Gross virus and other murine leukaemia viruses. J Exp Med 124: 753–772, 1966.

    Article  PubMed  CAS  Google Scholar 

  107. Grant CK, De Noronha F, Tusch C, Michalek MT, McLane MF. Protection of cats against progressive fibrosarcomas and persistent leukaemia virus infection by vaccination with feline leukaemia cells. J Natl Cancer Inst 65: 1285–1291, 1980.

    PubMed  CAS  Google Scholar 

  108. Ledbetter J, Nowinski RC, Emery S. Viral proteins on the surface of murine leukaemia cells. J Virol 22: 65–73, 1977.

    PubMed  CAS  Google Scholar 

  109. Hunsmann G, Moennig V, Schafer W. Properties of mouse leukaemia viruses. IX. Active and passive immunization of mice against friend leukaemia and isolated viral GP71 glycoprotein and to corresponding an-tiserum. Virology 66: 327–329, 1975.

    Article  PubMed  CAS  Google Scholar 

  110. De Noronha F, Baggs, R, Schafer W, Bolognesi DP. Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies. Nature 267: 54–56, 1977.

    Article  PubMed  Google Scholar 

  111. Rogers MJ, Law LW, Appella E. Solubilized TSTA and the major viral structural proteins gp70 and p30 in the immune response to murine leukaemia induced by Friend and Rauscher virus. Int J Cancer 20: 303–308, 1977.

    Article  PubMed  CAS  Google Scholar 

  112. Rees RC, Potter CW, Shelton J. The specificity of cellular immune reactions to three DNA virus-induced tumours as measured by the macrophage migration inhibition test. Europ J Cancer 11: 79–86, 1975.

    Article  CAS  Google Scholar 

  113. Sjogren HO, Minowada J, Ankerst J. Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med 125: 689–701, 1967.

    Article  PubMed  CAS  Google Scholar 

  114. Rees RC, Potter CW. In vivo studies of cell-mediated and humoral immune responses to adenovirus 12-induced tumour cells. Ach Ges Virusforsch 41: 116–126, 1973.

    Google Scholar 

  115. Blasecki JW, Tevethia SS. Restoration of specific immunity against SV40 tumour-specific transplantation antigens to lymphoid cells from tumour-bearing mice. Int J Cancer 16: 275–283, 1975.

    Article  PubMed  CAS  Google Scholar 

  116. Gooding LR. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. J Immunol 118: 920–927, 1977.

    PubMed  CAS  Google Scholar 

  117. Gooding LR. Specificities of killing by T-lymphocytes generated against syngeneic SV40 transformants: Studies employing recombinants with the H2 complex. J Immunol 122: 1002–1008, 1979.

    PubMed  CAS  Google Scholar 

  118. Gooding LR. T-lymphocyte effectors generated against SV40 transformed cells. J Immunol 121: 2328–2336, 1979.

    Google Scholar 

  119. Blasecki JW. Functional analysis of lymphoid cell subpopulations involved in rejection of tumours induced by simian virus 40. In Streilen JW, Hart DA, Stein-Streilen J, Duncan WR, Billingham RE (eds.), Hamster immune responses in infections and oncologic diseases. New York: Plenum Press, 1981, pp. 123–134.

    Google Scholar 

  120. Allison AC. Immune responses to polyoma virus-induced tumours. In Klein G. (ed.), Viral oncology. New York: Raven Press, 1980, pp. 481–488.

    Google Scholar 

  121. Schroder JW, Henning R, Molner RJ, Edelman GM. The recognition of H2 and viral antigens by cytotoxic T-cells. Cold Spring Harbour, Quant Biol 41: 547–558, 1976.

    Google Scholar 

  122. Doherty PC, Gotle D, Trinchieri G, Zinkernagel RM. Models for recognition of virally modified cells by immune thymus-derived lymphocytes. Immunogenetics 3: 517–524, 1976.

    Article  Google Scholar 

  123. Gooding LR, Edwards CB. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T-lymphocytes. J Immunol 124: 1258–1262, 1980.

    PubMed  CAS  Google Scholar 

  124. Campbell AE, Foley FM, Tevethia SS. Demonstration of multiple antigenic sites of the SV40 transplanta¬tion rejection antigen by using cytotoxic T-lymphocyte clones. J Immunol 130: 490–492, 1983.

    PubMed  CAS  Google Scholar 

  125. Mitulska ZB, Smith C, Alexander P. Evidence for an immunological reaction of the host directed against its own actively growing primary tumour. J Natl Cancer Inst 36: 29–35, 1966.

    Google Scholar 

  126. Barski G. Youn JK. Evolution of cell-mediated immunity in mice bearing an antigenic tumour. Influence of tumour growth and surgical removal. J Natl Cancer Inst 43: 111–112, 1969.

    PubMed  CAS  Google Scholar 

  127. Herberman RB, Aoki T, Nunn ME, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KSS. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst 53: 1103– 1111, 1974.

    Google Scholar 

  128. Blesecki JW, Tevethia SS. In vitro studies on the cellular immune response of tumour-bearing mice to SV40-transformed cells. J Immunol 114, 244–249, 1975.

    Google Scholar 

  129. Zarling JM, Tevethia SS. Transplantation immunity to Simian virus-40-transformed cells in tumour-bearing mice. I. Development of cellular immunity to Simian virus 40 tumour-specific transplantation antigen dur¬ing tumourigenesis by transplanted cells. J Natl Cancer Inst 50: 137–147, 1973.

    PubMed  CAS  Google Scholar 

  130. Rees RC, Potter CW. Immune response to adenovirus 12-induced tumour antigens, as measured in vitro by the macrophage migration inhibition test. Europ J Cancer 9: 497–502, 1973.

    Article  CAS  Google Scholar 

  131. Blesecki JW, Tevethia SS. In vitro assay of cellular immunity to tumour-specific antigen(s) of virus-induced tumours by macrophage migration inhibition. J Immunol 110: 590–594, 1973.

    Google Scholar 

  132. Mortensen RF, Ceglowski WS, Friedman H. In vitro assessment of cellular immunity to Rauscher leu¬kaemia virus. J Immunol 111: 657–660, 1973.

    Google Scholar 

  133. Datta SK, McCormick KJ, Trentin JJ. Induction of tumour-specific cell-mediated immunity by a non¬infectious type-C virus. Infect Immun 33: 126–129, 1981.

    PubMed  CAS  Google Scholar 

  134. Koppi TA, Halliday WJ. Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumours. I. Cell and serum activity detected by leukocyte adherence inhibiton. J Natl Cancer Inst 66: 1089–1096, 1981.

    PubMed  CAS  Google Scholar 

  135. Koppi TA, Halliday WJ, McKenzie IF. Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumours. II. Nature of blocking and unblocking factors in serum. J Natl Cancer Inst 66: 1097–1102, 1981.

    PubMed  CAS  Google Scholar 

  136. Nahmias AJ, Sawanabori S. The genital herpes-cervical cancer hypothesis—10 years later. Prog Exp Tumour Res 21: 117–125, 1978.

    CAS  Google Scholar 

  137. Shortland J, Mousway KM, Rees RC, Potter CW. Tumourigenicity of Herpesvirus hominis type 2 trans¬formed cells (line 333-8-9) in adult hamsters. J Path 129: 169–178, 1979.

    Article  PubMed  CAS  Google Scholar 

  138. Mousway KM, Rees RC, Potter CW, Shortland JR. Immune response of hamsters to transplanted herpes¬virus induced tumours. In Letnansky (ed.), Biology of the cancer cell. Kugler Medical Publ, 1980, pp. 127–132.

    Google Scholar 

  139. Walker JR, Rees RC, Teale DM, Potter CW. Properties of a Herpesvirus-transformed hamster cell line. I. Growth and culture characteristics of sublines of high and low metastatic potential. Europ J Cancer Clin Oncol 18: 1017–1026, 1982.

    Article  PubMed  CAS  Google Scholar 

  140. Gorlik E, Fogel M, Baetselier P, Katzav S, Feldman M, Segal S. Immunobiological diversity of metastatic cells. In Liotta LA, Hart IT (eds.), Immune invasion and metastases. The Hague: Martinus Nijhoff, 1982, pp. 133–146.

    Google Scholar 

  141. Levy JP, Leclerc JC. The murine sarcoma virus induced tumour: Exception or general model in tumour immunology. Adv Cancer Res 24: 1–66, 1977.

    Article  PubMed  CAS  Google Scholar 

  142. Gomard E, Duprez V, Reme T, Colombani MJ, Levy JP. Exclusive involvement of H-2db or H-2Kd products in the interaction between T-killer lymphocyte and syngeneic H-2b and H-2d viral lymphomas. J Exp Med 146: 909–922, 1977.

    Article  PubMed  CAS  Google Scholar 

  143. Gomard E, Levy JP, Plata F, Henin Y, Duprez V, Bismuth A, Reme T. Studies on the nature of the cell surface antigen reacting with cytolytic T-lymphocytes in murine oncornavirus-induced tumours. Europ J Immunol 8: 228–236, 1978.

    Article  CAS  Google Scholar 

  144. Enjuanes L, Lee I. Antigenic specificities of the cellular immune response of C57B1/6 mice to the Moloney leukaemia/sarcoma virus complex. J Immunol 122: 665–674, 1979.

    PubMed  CAS  Google Scholar 

  145. Zarling DA, Keshet I, Watson A, Bach FH. Association of mouse major histocompatibility and Rauscher murine leukaemia virus envelope glycoprotein antigens on leukaemia cells and their recognition by syngeneic virus-immune-cytotoxic T-lymphocytes. Scand J Immunol 8: 497–508, 1978.

    Article  PubMed  CAS  Google Scholar 

  146. Watson A, Bach FH. The role of gp70 in the target antigen recognised by murine leukaemia virus immune cytotoxic T-lymphocytes. Int J Cancer 26: 483–494, 1980.

    Article  PubMed  CAS  Google Scholar 

  147. Collins JJ, Sanfilippo F, Tsong-Chou L, Ishizaki R, Metzgar RS. Immunotherapy of murine leukaemia. I. Protection against Friend leukaemia virus-induced disease by passive serum therapy. Int J Cancer 21: 51–61, 1978.

    Article  PubMed  CAS  Google Scholar 

  148. Charman HP, Kim N, Gilden RV, Hardy WD Jr., Essex M. Humoral immune response of cats to feline leukaemia virus: Comparison of responses to the major structural protein p30 and to a virus-specific cell membrane antigen (FOCMA). J Natl Cancer Inst 57: 1095–1099, 1976.

    Google Scholar 

  149. Grant CK, Pickard DK, Ramaika C, Madewell BR, Essex M. Complement and tumour antibody levels in cats, and changes associated with natural feline leukaemia virus infection and malignant disease. Cancer Res 39: 75–81, 1979.

    PubMed  CAS  Google Scholar 

  150. Grant CK, Essex M, Gardner MB, Hardy WD Jr. Natural feline leukaemia virus infection and the immune response of cats of different ages. Cancer Res 40: 823–829, 1980.

    PubMed  CAS  Google Scholar 

  151. Herberman RB, Holden HT. Natural cell-mediated immunity. Adv Cancer Res 27: 305–377, 1978.

    Article  PubMed  CAS  Google Scholar 

  152. Rees RC, Underwood JCE. Tumour immunology. In Hancock BW (ed.), Assessment of tumour response. The Hague/Boston/London: Martinus Nijhoff, 1982, pp. 181–210.

    Google Scholar 

  153. Herberman RB. Natural killer cells and other natural effector cells. New York: Academic Press, 1982.

    Google Scholar 

  154. Hanna N. The role of natural killer (NK) cells in the control of tumour metastasis. In Liotta LA, Hart IR (eds.), Tumour Invasion and Metastases. The Hague: Martinus Nijhoff, 1982, pp. 29–41.

    Google Scholar 

  155. Fernandez-Cruz E, Halliburton B, Feldman JD. In vivo elimination by specific effector cells of an estab¬lished syngeneic rat Moloney virus-induced sarcoma. J Immunol 123: 1772–1777, 1979.

    Google Scholar 

  156. Platta F, MacDonald, HR, Sordat B. Studies on the distribution and origin of cytolytic T-lymphocytes present in mice bearing Moloney murine sarcoma virus (MSV)-induced tumours. Bibl Haematol 43: 274–277, 1976.

    Google Scholar 

  157. Becker S, Klein E. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice. J Natl Cancer Inst 65: 811–816, 1980.

    PubMed  CAS  Google Scholar 

  158. Stutman O. Natural and induced immunity to mouse mammary tumours and the mammary tumour virus (MuMTV). Springer Semin Immunopathoi 4: 333–372, 1982.

    Article  CAS  Google Scholar 

  159. Teale DM, Rees RC, Clark A, Walker JR, Potter CW. Reduced susceptibility of NK cell lysis of hamster tumours exhibiting high levels of spontaneous metastasis. Cancer Letters (in press).

    Google Scholar 

  160. Epstein MA, Achong BG. The Epstein-Barr virus. Berlin: Springer Verlag, 1979.

    Google Scholar 

  161. Lindahl T, Adams A, Bjursell G, Bornkamn GW, Kaschka-Dierick C, Jehn V. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102: 511–530, 1976.

    Article  PubMed  CAS  Google Scholar 

  162. Lindahl T, Klein G, Reedman BM, Johannson B, Singh S. Relationship between Epstein-Barr (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma and other lymphoproliferative malignancies. Int J Cancer 13: 764–772, 1974.

    Article  PubMed  CAS  Google Scholar 

  163. Josey WE, Nahmias AJ, Naib ZM. Viruses and cancer of the lower genital tract. Cancer 38: 526–533, 1976.

    Article  PubMed  CAS  Google Scholar 

  164. Melnick JL, Adam E. Epidemiological approaches to determining whether Herpesvirus is the etiological agent of cervical cancer. Prog Exp Tumour Res 21: 49–69, 1978.

    CAS  Google Scholar 

  165. Nahmias AJ, Naib ZM, Josey W. Epidemiological studies relating genital herpes to cervical cancer. Cancer Res 3: 1111–1117, 1974.

    Google Scholar 

  166. Rawls WE, Adam E. Herpes simplex viruses and human malignancies. In Hiatt, HH, Watson JD, Winston JA (eds.), Origins of Human Cancer. Cold Spring Harbour 4: 1133–1155, 1977.

    Google Scholar 

  167. Melnick JL, Adam E, Lewis R, Kaufman RH. Cervical cancer cell lines containing Herpesvirus markers. Intervirology 12: 111–114, 1979.

    Article  PubMed  CAS  Google Scholar 

  168. Aurelian L. Virions and antigens of Herpesvirus type 2 in cervical carcinoma. Cancer Res 33: 1539–1547, 1973.

    PubMed  CAS  Google Scholar 

  169. Frankel N. Roizman B, Cassai E, Nahmias A. A DNA fragment of herpes simplex 2 and its transcription in human cervical cancer tissue. Proc Natl Acad Sci 69: 3784–3789, 1972.

    Article  Google Scholar 

  170. Jones JW, Fenoglio CM, Shevchok-Chaban M, Maitland NJ, McDougallJK. Detection of herpes simplex virus type 2 mRNA in human cervical biopsies by in situ cytological hybridization. IARC Sci Publ 24: 917–925, 1979.

    Google Scholar 

  171. Kessler I. Human cervical cancer as a venereal disease. Cancer Res 36: 783–791, 1976.

    PubMed  CAS  Google Scholar 

  172. Ishiguro T, Ozarki Y. Antibodies to herpes simplex virus in cervical cancer. Adv Obstet Gynecol (Jpn) 30: 9–13, 1978.

    Google Scholar 

  173. Ory H. Conger B, Richart R, Barron B. Relation of type 2 Herpesvirus antibodies to cervical neoplasia: Barbados, West Indies, 1971. Obstet Gynecol 43: 901–904, 1974.

    Google Scholar 

  174. Vestergaard BF, Hornsleth A, Pedersen SN. Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Cancer 30: 68–74, 1972.

    Article  PubMed  CAS  Google Scholar 

  175. Reid R, Stanhope CR, Herschman BR, Booth E, Phibbs GD, Smith JP. Genital warts and cervical cancer. Cancer 50: 377–387, 1982.

    Article  PubMed  CAS  Google Scholar 

  176. Green M, Brackman KH, Sanders PR, Loewenstein PM, Freel JH, Eisinger M, Switlyx SA. Isolation of a human Papillomavirus from a patient with epidermodysplasia verruciformis. Proc Natl Acad Sci 79: 4437– 4441, 1982.

    Google Scholar 

  177. Gissmann L, de Villiers EM, Zur Hausen H. Analysis of human genital warts (condylomata acuminata) and other genital tumours for human Papillomavirus type 6 DNA. Int J Cancer 29: 143–146, 1982.

    Google Scholar 

  178. Zur Hausen H. Human Papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78: 1–30, 1977.

    PubMed  Google Scholar 

  179. Orth G, Faure M, Jablonska S, Brylak K, Croissant O. Viral sequences related to a human skin Papilloma¬virus in genital warts. Nature 275: 334–336, 1978.

    Article  PubMed  CAS  Google Scholar 

  180. Zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 36: 794, 1976.

    PubMed  Google Scholar 

  181. Friedman-Kien AE. Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Amer Acad Dermatol 5: 468–471, 1981.

    Article  CAS  Google Scholar 

  182. Hymes KB, Greene JB, Marcos A, William DC, Cheung T, Prose NS, Ballard H, Laubenstein LJ. Kaposi’s sarcoma in homosexual men. Lancet 2: 598–600, 1981.

    Article  PubMed  CAS  Google Scholar 

  183. Giraldo G, Beth E, Henle W, Henle G, Mike V, Safai B, Huraux JM, McHardy J, de The G. Antibody pat¬terns to Herpesviruses in Kaposi’s sarcoma. Int J Cancer 22: 126–131, 1978.

    Google Scholar 

  184. Tong MG, Sun SC, Schaeffer BT. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 75: 687–691, 1971.

    PubMed  CAS  Google Scholar 

  185. Beasley RP, Hwana LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129–1133, 1981.

    Google Scholar 

  186. Edman JC, Gray P, Valenzuela P, Rail LB, Rutter WJ. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 286: 535–538, 1980.

    Article  PubMed  CAS  Google Scholar 

  187. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA se¬quences in cellular DNA of human hepatocellular carcinoma. Nature 286: 533–535, 1980.

    Article  PubMed  CAS  Google Scholar 

  188. Johnson PJ, Williams R. Of woodchucks and man: The continuing story of hepatitis B and hepatocellular carcinomas. Brit Med J 284: 1586–1588, 1982.

    Google Scholar 

  189. Howley PM. DNA sequences of human Papovavirus BK. Nature 284: 124–125, 1980.

    Article  PubMed  CAS  Google Scholar 

  190. Schernecks S, Rudolph M, Geissler E. Isolation of an SV40-like Papovavirus from a human glioblastoma. Int J Cancer 24: 523–531, 1979.

    Article  Google Scholar 

  191. Brovet JC, Flandrin G, Seligmann M. Indication of the thymus derived nature of the proliferating cells in six patients with Sezary’s syndrome. N Eng J Med 289: 341–344, 1973.

    Article  Google Scholar 

  192. Thivolet J, Fulton R, Souteyrand P, Gaucherand M, Claudy A. Sezary syndrome: Relative increase in T helper lymphocytes demonstrated by monoclonal antibodies. Acta Derm Venereal 62: 337–340, 1982.

    CAS  Google Scholar 

  193. Edelson RL. Cutaneous T cell lymphoma: Mycosis fungoides, Sezary syndrome and other variants. J Amer Acad Dermatol 2: 89–106, 1980.

    Article  CAS  Google Scholar 

  194. Neth R, Gallo RC, Graff K, Mannweiler K. Regulation of human T-cell proliferation: T-cell growth factor and isolation of a new class of type-C retroviruses. In Winkler K (ed.), Modern trends in human leukaemia 4: 502–514, 1981.

    Google Scholar 

  195. Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister A, Galton DAG, Sarin PS, Crawford MH, Catousky D, Greaves M, Gallo RC. The human type-C retrovirus HTLV in blacks from the Caribbean region and relationship to adult T-cell leukaemia/lymphoma. Int J Cancer 30: 257–264, 1982.

    Article  PubMed  CAS  Google Scholar 

  196. Bishop JM. Retrovirus and cancer genes. Adv Cancer Res 37: 1–32, 1982.

    Article  PubMed  CAS  Google Scholar 

  197. Syrjanen KJ. Demonstration of human Papillomavirus antigen in the condylomatous lesions of the uterine cervix. Lancet 2: 125–127, 1982.

    Google Scholar 

  198. Maupas PH, Goudeau A, Coursaget P, Chiron JP, Drucker J, Barin F, Perrin J, Denis F, Diopmar I. Hepatitis B virus infection and primary hepatocarcinoma. In Essex M, Tadoro G, Zur Hausen H (eds.), Viruses and naturally occurring cancer. Cold Spring Harbour Conference on Cell Proliferation 7: 481–506, 1980.

    Google Scholar 

  199. Normura A, Grant N, Stemmerman N, Wasnick RD. Presence of hepatitis B surface antigen before pri¬mary hepatocellular carcinoma. JAMA 247: 2247–2249, 1982.

    Article  Google Scholar 

  200. Melnick JL, Adam E, Lewis R, Kaufman RH. Cervical cancer cell lines containing Herpesvirus markers. Intervirol 12: 111–114, 1979.

    Article  CAS  Google Scholar 

  201. Dreesman GR, Burch J, Ada E, Kaufman RH, Melnick JL, Powell KL, Purifoy DJ. Expression of Herpes- virus-induced antigens in human cervical cancer. Nature 283: 591–593, 1980.

    Article  PubMed  CAS  Google Scholar 

  202. Smith CC, Aurelian L, Gupta PK, Frost JK, Rosenhein NB, Klacsmann K, Geddes S. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia. Anal- Quant Cytol 2: 131–143, 1980.

    PubMed  CAS  Google Scholar 

  203. Hollinshead AC, Tarro C. Soluble membrane antigens of LIP and cervical carcinomas. Science 179: 698–700, 1973.

    Article  PubMed  CAS  Google Scholar 

  204. Gall SA, Haines HG. Cervical carcinoma antigen and the relationship to HSV-2. Gynecol Oncol 2: 451–459, 1974.

    Article  CAS  Google Scholar 

  205. Notter MF, Docherty JJ, Mortel R, Hollinshead AC. Detection of herpes simplex vims tumour-associated antigen in uterine cervical cancer tissue. Gynecol Oncol 6: 574–581, 1978.

    Article  PubMed  CAS  Google Scholar 

  206. Weiner LP, Herndon RM, Johnson RT. Viral infections and demyelinating diseases. N Eng J Med 288: 1103–1110, 1973.

    Article  CAS  Google Scholar 

  207. Weiner LP, Narayan O. Virological studies in progressive multifocal leukoencephalopathy. Prog Med Virol 18: 229–240, 1974.

    PubMed  CAS  Google Scholar 

  208. Weiss AF, Portmann R, Fischer H, Simon J, Zang KD. Simian virus 40-related antigens in three human meningiomas with defined chromosome breaks. Proc Natl Acad Sci 72: 609–613, 1975.

    Article  PubMed  CAS  Google Scholar 

  209. Pope JH, Home MK, Wetters EJ. Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature 222: 186–187, 1969.

    Article  PubMed  CAS  Google Scholar 

  210. Reedman BM, Klein G. Cellular localisation of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer cells and non-producer lymphoblastoid cell lines. Int J Cancer 11: 499–520, 1973.

    Article  PubMed  CAS  Google Scholar 

  211. Zur Hausen H. Biochemical approaches to detection of Epstein-Barr virus in human tumours. Cancer Res 36: 678–681, 1976.

    PubMed  Google Scholar 

  212. Henle W, Henle G, Zagac B, Pearson G, Waubke R, Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169: 188–189, 1970.

    Article  PubMed  CAS  Google Scholar 

  213. Svedmyr E, Jondal M. Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci 72: 1622–1628, 1975.

    Article  PubMed  CAS  Google Scholar 

  214. Levine AJ. Transformation-associated tumour antigens. Adv Cancer Res 37: 75–109, 1982.

    Article  PubMed  CAS  Google Scholar 

  215. Crawford LV, Pim DC, Gurney EG. Goodfellow P, Taylor-Papadimitrou A. Detection of a common feature in several human tumour lines—A 53,000-dalton protein. Proc Natl Acad Sci 787: 41–45, 1981.

    Article  Google Scholar 

  216. Catovsky D, Greaves MF, Rose M, Galton DAG, Goolden AWG, McCluskey DR, White JM, Lampert I, Bourikas G, Ireland R, Bridges JM, Blather WAC, Gallo RC. Adult T-cell lymphoma leukaemia in blacks from the West Indies. Lancet 1: 639–643, 1982.

    Article  PubMed  CAS  Google Scholar 

  217. Tomana M, Kajdos AH, Niedeimeier W, Durkin WJ, Mestecky J. Antibodies to mouse mammary tumour virus-related antigen in sera of patients with breast carcinoma. Cancer 47: 2696–2703, 1981.

    Article  PubMed  CAS  Google Scholar 

  218. Zachrau RE, Black MM, Dion AS, Shore B, Isac M, Andrade AM, Williams CJ. Prognostically significant protein components in human breast cancer tissue. Cancer Res 36: 3143–3146, 1976.

    PubMed  CAS  Google Scholar 

  219. Mesa-Tejada R, Oster MW, Fenoglio CM, Majidson J, Spiegelman S. Diagnosis of primary breast carcinoma through immunochemical detection of antigen related to mouse mammary tumour virus metastatic lesions: A report of two cases. Cancer 15: 261–268, 1982.

    Google Scholar 

  220. Black MM, Zachrau RE, Dion AS, Shire B, Fine DL, Leis HP Jr, Williams CJ. Cellular hypersensitivity to gp55 of Rlll-murine tumour virus and gp55-like protein of human breast cancers. Cancer Res 36: 4137– 4142, 1976.

    Google Scholar 

  221. Cannon GB, Barsky SH, Alford TC, Jerome LF, Tinley V, McCoy JL, Dean JH. Cell-mediated immunity to mouse mammary tumour virus antigens by patients with hyperplastic benign breast disease. J Natl Cancer Inst 68: 935–943, 1982.

    PubMed  CAS  Google Scholar 

  222. Holder WD Jr, Wells SA Jr. Antibody reacting with the murine mammary tumour virus in the serum of patients with breast carcinoma: A possible serological detection method for breast carcinoma. Cancer Res 43: 239–244, 1983.

    PubMed  Google Scholar 

  223. Hewetson JF, Levine PH, Neubauer RH. Rubin H. Discordant Epstein-Barr virus molecular antigen (EBNA) antibody patterns in nasopharyngeal carcinoma. Int J Cancer: 581–585, 1982.

    Google Scholar 

  224. Falaky IHE, Vestergaard BF. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix. Europ J Cancer 13: 247–251, 1977.

    Article  Google Scholar 

  225. Pasca AS, Kummerlauder L, Pejtsik B, Pali K. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst 55: 775–781, 1975.

    Google Scholar 

  226. Cristenson B. Antibody-dependent cell-mediated cytotoxicity to HSV transformed cells in the course of cervical carcinoma. Am J Epidemiol 115: 556–568, 1982.

    PubMed  CAS  Google Scholar 

  227. Arsenakis M, May JT, Cauchi MN. Antibody to AG-4 and survival of carcinoma of the cervix patients. Lancet 2: 437, 1981.

    Article  Google Scholar 

  228. Heise ER, Kucera LS, Raben M, Homesley H. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients. Cancer Res 39: 4022–4026, 1979.

    PubMed  CAS  Google Scholar 

  229. Christenson B, Espmark A. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of herpes simplex virus infected cells. Int J Cancer 17: 318–325, 1976.

    Article  PubMed  CAS  Google Scholar 

  230. Christenson B. Antibody-dependent cell-mediated cytotoxicity to herpes simplex virus type 2 infected target cells, in the course of cervical carcinoma. Amer J Epidem 108: 126–135, 1978.

    CAS  Google Scholar 

  231. Notter MFD, Docherty JJ. Reaction of antigens isolated from herpes simplex virus-transformed cells of squamous cell carcinoma patients. Cancer Res 36: 4394–4401, 1976.

    PubMed  CAS  Google Scholar 

  232. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human Papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Amer J Epidem 102: 331 - 340, 1975.

    CAS  Google Scholar 

  233. Gardner SD. Prevalence in England of antibody to human Polyomavirus (BK). Brit Med J 1: 77–78, 1973.

    Article  PubMed  CAS  Google Scholar 

  234. Padgett BL, Walker DL. New human Papovaviruses. Progr Med Virol 22: 1–35, 1976.

    CAS  Google Scholar 

  235. Penn I. Tumours arising in organ transplant recipients. Adv Cancer Res 28: 31–61, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. W. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. C. Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Sheffield, UK

    B. W. Hancock (Senior Lecturer in Medicine Honorary Consultant Physician) (Senior Lecturer in Medicine Honorary Consultant Physician)

  2. Royal Hallamshire Hospital, Sheffield, S10 2JF, UK

    B. W. Hancock (Senior Lecturer in Medicine Honorary Consultant Physician) & A. Milford Ward (Senior Lecturer in Immunology Director of Supraregional Protein Reference Unit) (Senior Lecturer in Medicine Honorary Consultant Physician) &  (Senior Lecturer in Immunology Director of Supraregional Protein Reference Unit)

  3. Weston Park Hospital, Sheffield, S10 2JF, UK

    B. W. Hancock (Senior Lecturer in Medicine Honorary Consultant Physician) (Senior Lecturer in Medicine Honorary Consultant Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston/Dordrecht/Lancaster

About this chapter

Cite this chapter

Potter, C.W., Rees, R.C. (1985). Viruses, Immunity, and Cancer. In: Hancock, B.W., Milford Ward, A. (eds) Immunological Aspects of Cancer. Developments in Oncology, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2557-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2557-4_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9607-2

  • Online ISBN: 978-1-4613-2557-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation